GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,360,000 | +274.5% | 210,900 | +75.8% | 0.20% | +280.8% |
| Q2 2022 | $3,834,000 | +84.5% | 120,000 | +100.0% | 0.05% | +116.7% |
| Q1 2022 | $2,078,000 | -72.3% | 60,000 | -79.7% | 0.02% | -72.1% |
| Q3 2021 | $7,513,000 | -32.0% | 294,846 | -6.5% | 0.09% | -40.3% |
| Q2 2021 | $11,043,000 | +982.6% | 315,200 | +1160.8% | 0.14% | +554.5% |
| Q1 2021 | $1,020,000 | -89.1% | 25,000 | -88.4% | 0.02% | -89.7% |
| Q4 2020 | $9,371,000 | +133.2% | 216,412 | +196.9% | 0.21% | +127.7% |
| Q3 2020 | $4,019,000 | -32.5% | 72,900 | -22.8% | 0.09% | -52.8% |
| Q2 2020 | $5,957,000 | -19.5% | 94,370 | +1.4% | 0.20% | -19.8% |
| Q4 2019 | $7,397,000 | +8.9% | 93,042 | -33.5% | 0.25% | -29.7% |
| Q3 2019 | $6,793,000 | -24.5% | 140,000 | -18.1% | 0.35% | -22.1% |
| Q2 2019 | $8,996,000 | +180.9% | 171,000 | +182.7% | 0.45% | +157.4% |
| Q1 2019 | $3,202,000 | +218.0% | 60,496 | +128.1% | 0.18% | +214.3% |
| Q3 2018 | $1,007,000 | -52.5% | 26,518 | -43.5% | 0.06% | -66.1% |
| Q2 2018 | $2,120,000 | – | 46,900 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |